C WorldWide Group’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-30,798
Closed -$588K 139
2018
Q3
$588K Sell
30,798
-5,648
-15% -$202K 0.01% 118
2018
Q2
$2.06M Buy
36,446
+6,648
+22% +$337K 0.03% 94
2018
Q1
$1.26M Sell
29,798
-5,915
-17% -$254K 0.02% 95
2017
Q4
$1.91M Sell
35,713
-13,620
-28% -$719K 0.03% 89
2017
Q3
$2.2M Sell
49,333
-768
-2% -$35K 0.03% 91
2017
Q2
$2.44M Sell
50,101
-2,355
-4% -$139K 0.04% 90
2017
Q1
$3.8M Buy
52,456
+15,456
+42% +$1.02M 0.06% 67
2016
Q4
$2.12M Buy
37,000
+12,000
+48% +$1.1M 0.04% 81
2016
Q3
$3.2M Buy
+25,000
New +$3.2M 0.06% 70

Other funds holding ELGX

C WorldWide Group's ELGX Position: Q4 2018 in Review

C WorldWide Group sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 30,798 shares — an estimated $588K sold.

C WorldWide Group first reported a position in ELGX in Q3 2016 and held it in 9 quarters. The position peaked at $3.8M in Q1 2017. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • C WorldWide Group reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • C WorldWide Group sold 30,798 Endologix Inc shares in Q4 2018, an estimated $588K.
  • C WorldWide Group first reported a position in Endologix Inc in Q3 2016 and held it in 9 quarters.
  • C WorldWide Group's Endologix Inc position peaked at $3.8M in Q1 2017.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.